Status:
ACTIVE_NOT_RECRUITING
MyoVasc Study on the Development and Progression of Heart Failure
Lead Sponsor:
Johannes Gutenberg University Mainz
Conditions:
Heart Failure
Eligibility:
All Genders
35-84 years
Brief Summary
The MyoVasc - Study is an observational, prospective cohort study. The study is investigating the development and progression of the heart failure syndrome, phenotypes of the heterogeneous syndrome, a...
Detailed Description
"MyoVasc" is an observational cohort study investigating the development and progression of heart failure (HF). The primary objective of the study is: i, to advance the understanding of pathomechanism...
Eligibility Criteria
Inclusion
- Asymptomatic heart failure or symptomatic heart failure
- Written consent
- Sufficient knowledge of the German language, in order to understand study documents and computer assisted interview without any translation
Exclusion
- Individuals who are not able to visit the study center due to psychological or physical impairment
- STEMI within the last 4 months, NSTEMI within the last 3 months
- Acute decompensated heart failure
- Surgery, especially coronary artery bypass grafting within the last 3 months
- Acute disease, especially acute infectious disease, endocarditis, myocarditis or pericarditis
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2028
Estimated Enrollment :
3289 Patients enrolled
Trial Details
Trial ID
NCT04064450
Start Date
January 1 2013
End Date
December 1 2028
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center of the Johannes Gutenberg-University Mainz
Mainz, Rhineland-Palatinate, Germany, 55131